Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» AstraZeneca lung cancer immunotherapy trial failure sends shares plunging
AstraZeneca lung cancer immunotherapy trial failure sends shares plunging
AstraZeneca lung cancer immunotherapy trial failure sends shares plunging
Submitted by
admin
on July 27, 2017 - 9:59am
Source:
Stat
News Tags:
AstraZeneca
Mystic
immuno-oncology
clinical trials
tremelimumab
Imfinzi
Headline:
AstraZeneca lung cancer immunotherapy trial failure sends shares plunging
Do Not Allow Advertisers to Use My Personal information
